K-Patch
Recruits breast circulating tumor cells (CTCs) to the topical area. K-Patch reduced the amount of CTCs cells in the mice and decreased total tumor burden. Product is currently in pre-Phase I stage of the development. Other K-Patches are developed for other types of human malignancies. Please contact us for more details.
K-Patch
In the breast tumor model, application of K-Patch decreased metastasis of cancer cells to lung tissue. The image on the right shows tissue immunohistochemistry (IHC) staining of the experimental group of lung tissue.
‘The Compound’ for Radiodermatitis
We are developing herbal-based compounds that can help prevent and alleviate radiodermatitis. The projects is testing out the efficacy of the compounds in large group animal experiments.
‘The Compound’
‘The Compound’ is a herbal-based medicine that helps prevent and alleviate radiodermatitis. The design and production of the compounds is based on intensive lab work, particularly animal experiments. The efficacy is currently evaluations. The development of the compound is contracted project, in which Kancure designs and executes the experiments.
